2020 Market Analysis of International Conference on Biotechnology and Healthcare

GLOBAL PRESENCE OF YOUR RESEARCH AT BIOTECHNOLOGY CONGRESS 2020 SCHEDULED DURING DECEMBER 02-03, 2020 AUCKLAND, NEW ZEALAND

The Global Biopharmaceutical Market is poised to grow at a CAGR of around 10.1% over the next decade to reach approximately $459.81 billion by 2025.The opportunity in biopharmaceuticals is big and growing too rapidly to ignore. Today biopharmaceuticals generate global revenues of $163 billion, making up about 20%of the Pharma market. It’s by far the fastest-growing part of the industry. Biopharma and Technology current annual growth rate of more than 8% is double that of conventional Pharma, and growth is expected to continue at that rate for the foreseeable future.

It is estimated at USD 215 million for the year 2017 and is projected to reach USD 269 billion by the year 2021. The estimated CAGR during the forecast period (2017-2021) is 5.76%. The pharmaceutical market in Asia is set to rise from around $70 billion in 2016 to $72 billion by 2021, representing a low compound annual growth rate of 0.3%, according to Global Data, a recognized leader in providing business information and analytics. The penetration of generics has grown robustly over the past few years. The government has also made a target towards achieving a generic penetration of 60% by 2018. This is expected to create huge opportunities for both domestic and foreign generic manufacturers in World.

The biggest change for Pharma in Asia was the 2014 revision of the nation’s keystone pharmaceuticals law, renamed the PMD Act-for pharmaceutical and medical devices. Japanese officials proudly say some drug approvals in Japan are now faster than in both Europe and the U.S.

IMPORTANCE & SCOPE

Biotechnology Congress 2020 aims to find advances to bring the gathering in London, UK. The biotechnology market in UK has seen huge activity this year in each the areas of commercial biotechnology and in alternative fields. They partner with completely different industries of Biotechnology. They need immense networks of partnering. Since its commencement, Biotechnology series has witnessed around 940 analysers of nice skills and exceptional research shows from round the world. Attention of Biotechnology and its applications wide current among the common population. Progressive developments within the business have led to several breakthroughs within the applications across the medical, agricultural, aquatic and industrial fields. Extending normality of diseases, as an example, hepatitis B, danger, and another vagrant issue square measure needed to fuel fire during this house.

Recent biotechnology develops new merchandise and technologies to fight diseases, cut back our environmental damage, feed the hungry, use less and cleaner energy, and have safer, cleaner and additional economical industrial producing processes.

TARGET AUDIENCE

• Directors, CEO’s of Organizations

• Business Development Managers

• Chief Scientific Officers

• R&D Researchers from Biotechnology Industries

• Professors, Associate Professors, Assistant Professors

• PhD Scholars

• Patent Attorneys

• Investment Analysts

• Association, Association presidents and professionals

• Noble laureates in Health Care and Medicine

• Bio instruments Professionals

• Bio-informatics Professionals

• Software development companies

• Research Institutes and members

• Supply Chain companies

• Manufacturing Companies

• CRO and DATA management Companies

• Training Institutes

RELATED COMPANIES/INDUSTRIES

• Abacus Biotech Limited

• Association of Crown Research Institutes Inc. (ACRI)

• AgBioResearch Ltd

• Agcarm Incorporated

• AgResearch

• AgResearch Grasslands Research Centre

• AgResearch Wallaceville Animal Research Centre

• Agrimm Technologies Limited

• AgVax Developments Ltd

• AJ Park

• Alltech Associates Inc.

• Animal Health Services Centre, Massey University

• ANZCO Foods Ltd

• Auckland UniServices Limited

• Baldwins

• Bell Gully

• Bio International Limited

• bio-strategy

• BioActive Technologies International Ltd

• BioCatalyst

RELATED ASSOCIATIONS AND SOCIETIES

• Italian Society of Biochemistry and Molecular Biology

• European Society for Precision Engineering and Nanotechnology

• Pharmaceutical Society of Australia

• Spanish Society of Biotechnology

• Society for Chemical Engineering Biotechnology

• Manchester University Pharmaceutical Society

• The Pharmaceutical Society of Ireland

• International Society for Pharmaceutical Engineering

• Romanian Society of Medical Mycology and Mycotoxicology

• New Zealand Plant Protection Society

• Russian Medical Society

• Society for Engineering in Agriculture